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Abstract
Zika virus is a mosquito-borne Flavivirus originally isolated from humans in 1952. Following its re-emergence in Brazil 
in 2015, an increase in the number of babies born with microcephaly to infected mothers was observed. Microcephaly is a 
neurodevelopmental disorder, characterised phenotypically by a smaller than average head size, and is usually developed in 
utero. The 2015 outbreak in the Americas led to the World Health Organisation declaring Zika a Public Health Emergency 
of International Concern. Since then, much research into the effects of Zika has been carried out. Studies have investigated 
the structure of the virus, its effects on and evasion of the immune response, cellular entry including target receptors, its 
transmission from infected mother to foetus and its cellular targets. This review discusses current knowledge and novel 
research into these areas, in hope of developing a further understanding of how exposure of pregnant women to the Zika 
virus can lead to impaired brain development of their foetus. Although no longer considered an epidemic in the Americas, 
the mechanism by which Zika acts is still not comprehensively and wholly understood, and this understanding will be crucial 
in developing effective vaccines and treatments.
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Introduction
Microcephaly
Microcephaly is a diagnosis given to neonates born with sig-
nificantly smaller heads than expected. The accepted criteria 
for a diagnosis of microcephaly is a head circumference of 
three standard deviations or more below the mean for sex 
and gestational age of the healthy reference population [1]. 
Head circumference is used as a measurement of brain size, 
as microcephaly bears a strong correlation with mental retar-
dation. Although the brain is smaller, it is architecturally 
normal, with reduced brain volume being due to the reduced 
size of the cerebral cortex [2].
Microcephaly can be primary or secondary; primary 
microcephaly is present at birth, usually a developmental 
anomaly due to disturbed neurogenesis or death of neuronal 
progenitors [3], whereas secondary microcephaly develops 
after birth, indicating a progressive neurodegenerative dis-
order. Primary microcephaly can have many non-genetic and 
genetic causes. For example, various congenital infections 
such as Toxoplasma gondii, Zika Virus (ZIKV), Cytomeg-
alovirus, Herpes Simplex Virus and Rubella Virus show 
strong causal evidence to suggest that they result in primary 
microcephaly and mental retardation [3]. Other factors such 
as excess alcohol consumption during pregnancy and Ruben-
stein Taybi syndrome can also result in primary microceph-
aly [2]. These causes must be excluded before a diagnosis 
of autosomal recessive primary microcephaly (MCPH) can 
be reached.
Autosomal recessive primary microcephaly
In order to understand how ZIKV causes microcephaly in 
infected foetuses, and its viral targets, we will first inves-
tigate genes and molecules known to be associated with 
this condition. Genetic forms of primary microcephaly 
(collectively known as MicroCephaly Primary Hereditary 
(MCPH) are rare, genetically heterogeneous disorders which 
are inherited recessively and cause a large reduction in brain 
growth in utero [4].
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Autosomal recessive primary microcephaly (MCPH) is 
the result of deficient neurogenesis within the neurogenic 
epithelium. It remains unclear as to why mutations in these 
genes only affect the brain, but it is thought to be due to 
the elongated morphology of neuronal cells and the pre-
cise nature in which the last stage of the cytokinesis cleav-
age furrow has to be executed. The furrow must bisect the 
cadherin hole (a small apical-membrane fate-determining 
domain) precisely to ensure that the division producing two 
daughter cell neural precursors is perfectly symmetrical [5].
Jackson et al. [6] and Roberts et al. [26] reported the ini-
tial defining clinical features of MCPH to be:
1. Congenital microcephaly at least four standard devia-
tions below the population mean for age and sex
2. Mental retardation as the only neurological finding. 
Symptoms such as spasticity, seizures, or progressive 
cognitive decline rule out MCPH
3. Normal height and weight, appearance, and results on 
chromosome analysis and brain scan
There have been eighteen genes reported to be associated 
with MCPH thus far, identified from different populations 
worldwide (Table 1).
Genes implicated in this condition have effects on vary-
ing pathways. The pathways involved include: DNA repair, 
transcription regulation, cell cycle progression including 
checkpoint regulation, binding of dynein, centrosome dupli-
cation, proliferative capacity of neural progenitor cells and 
interference with mitotic spindle formation. These path-
ways may be crucial in understanding ZIKV infection and 
subsequent microcephaly in foetuses. Recent proteomics 
studies exploring the ZIKV-host interactome have identi-
fied, amongst an extensive array of cellular targets, networks 
associated with signalling and mitotic pathways [27–30]. For 
example, Golubeva et al. identify shared interactions with 
14 of the reported MCPH-related genes [30].
Globally, ASPM and WDR62 are the most commonly 
implicated genes, contributing to over 50% of gene muta-
tions found in MCPH [31]. Most cases of MCPH are caused 
by point mutations within these genes involved in mitosis. 
For example, the ASPM gene encodes a spindle pole pro-
tein [32], WDR62 associates and interacts with the spindle 
assembly factor Aurora A to regulate mitotic progression 
and spindle formation [33], and STIL encodes a pericentri-
olar and centrosomal protein [14].
MCPH is inherited, and is most common in areas where 
consanguineous marriage is practiced. The incidence is 
around 1 in 10,000 in consanguineous populations, but this 
figure is lower in non-consanguineous populations [34], esti-
mated to be 1–3 per 100,000 births in the Western world 
[35].
Table 1  The eighteen mapped MCPH loci, their attributed genes, proposed function and key reference(s)
Loci Attributed gene Proposed function Key reference
MCPH1 MCPH1/Microcephalin DNA repair, chromosome condensation, telomerase repression [6, 7]
MCPH2 WDR62 Mitotic progression [8]
MCPH3 CDK5RAP2 Microtubule function, maturation of centrosome, spindle checkpoint [9]
MCPH4 CASC5 Kinetochore assembly, spindle assembly checkpoint, chromosome segregation [10]
MCPH5 ASPM Spindle and cleavage furrow orientation, cytokinesis, spindle assembly, mitotic progression 
and differentiation, dsDNA break repair, regulator of Wnt signalling
[11, 12]
MCPH6 CENPJ/CPAP Centriole length, microtubule assembly, spindle positioning [13]
MCPH7 STIL Control of cell cycle, organization of spindle, pro-centriole formation [14]
MCPH8 CEP135 Microtubule organization, centriole structure [15]
MCPH9 CEP152 Centriole duplication and assembly [16]
MCPH10 CEP63 Centriole biogenesis, centrosome localisation, genome maintenance [17]
MCPH11 PHC1 Contained in a complex which is involved in maintaining transcriptional repression of many 
genes via chromatin remodelling and histone modification
[18]
MCPH12 CDK6 Cell cycle control [19]
MCPH13 ZNF335 Gene expression through the regulation, targeting and stability of the H3K4 methyltrans-
ferase complex. Also regulates differentiation and transcription in post-mitotic neurons
[20]
MCPH14 CIT Promotion of efficient cytokinesis, central nervous system development [21]
MCPH15 PLK4 Regulates centriole duplication [22]
MCPH16 SAS-6 Central component of centrioles, necessary for their duplication and function [23]
MCPH17 TUBGPC Tbc—direct phosphorylation target of PLK4, so likely to act through the same pathway in 
causing microcephaly
[24]
MCPH18 WDFY3 Autophagy scaffold protein, regulator of Wnt signalling [25]
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ASPM
The abnormal spindle-like microcephaly-associated (ASPM) 
gene is found at the MCPH5 locus, and encodes a nuclear 
mitotic spindle pole associated protein [32]. ASPM is the 
human orthologue of the abnormal spindle gene (asp) found 
in Drosophila melanogaster, and is essential in the func-
tion of normal mitotic spindles in embryonic neuroblasts 
[11, 36]. Mouse Aspm is expressed in the primary sites of 
prenatal cerebral cortical neurogenesis [11]. Asp is essen-
tial for the organisation and bundling of microtubules at the 
spindle poles during cell division, and is necessary for the 
correct development of the mitotic spindles [37]. During 
interphase, ASPM is localised to the centrosome. During 
mitosis, from prophase to telophase, ASPM is localised at 
the spindle poles.
ASPM has been established to contribute to the evolution 
of the brain both in humans and in other primates [38–40]. 
ASPM in mice encodes a protein associated with the centro-
some [11] and the midbody [32, 41]. It is expressed during 
neurogenesis primarily in the ventricular zone of the neocor-
tex [11, 26, 42] and is important in determining the position 
of the spindle poles in apical progenitor cells, allowing them 
to divide symmetrically during mitosis [42].
WDR62
Mutations in WDR62 (MCPH2) are the second most com-
mon cause of MCPH, after ASPM mutations, and it encodes 
a spindle pole protein [2]. The expression pattern of WDR62 
during mitosis was found to be identical to that of ASPM in 
that WDR62 was concentrated at the spindle poles but was 
not present at the midbody during cytokinesis [5].
This awareness of identified microcephaly-related genes 
raises the question as to whether the expression of these 
MCPH genes is affected by ZIKV infection. Additionally, 
mutations in these genes are understood to cause mitotic 
defects, therefore the question arises as to whether this is 
a mechanism employed by ZIKV in causing microcephaly.
Zika virus
ZIKV is a positive-stranded RNA virus within the Flaviviri-
dae family belonging to the same genus, Flavivirus, as Den-
gue and West Nile Viruses (DENV and WNV respectively) 
and is transmitted through Aedes spp. mosquitos. The virus 
was first isolated in the Zika forest in Entebbe, Uganda, in 
1947, from a rhesus monkey. It was then isolated from mos-
quitos in 1948 and humans in 1952 [43]. Urban transmission 
of the virus is maintained primarily in an infection cycle 
between humans and predominantly A. aegypti mosquitoes 
in tropical/sub-tropical regions; however transmission has 
also been reported via A. albopictus, which has a wider geo-
graphical distribution, including more temperate regions.
Acute clinical symptoms of ZIKV infection in adults 
are similar to those of other mosquito transmitted arbovi-
rus such as dengue fever and chikungunya, displaying as 
fever, arthralgia, myalgia, headache and maculopapular rash. 
Other symptoms, such as neurological manifestations and 
Guillain–Barré syndrome, were described during ZIKV out-
breaks in French Polynesia and Brazil [44–46]. Despite their 
close phylogenetic relationship, ZIKV is the only member 
of the Flavivirus genus that is classified as a teratogen, or 
an agent that intervenes with the foetal development process 
[47].
Prior to 2015, ZIKV had been responsible for outbreaks 
and epidemics mostly in remote islands, including Yap 
Island and Micronesia in 2007, when an estimated 75% 
of the population of Yap Island became infected within a 
4 month period [48]. There were also outbreaks in French 
Polynesia, New Caledonia, the Cook Islands and Easter 
Island in 2013 and 2014 [49, 50]. The virus was detected 
in the Americas, most notably in Brazil, in early 2015 [51].
The ZIKV genome is a single-stranded, positive-sense 
RNA molecule of ~ 10.8 kilobases (kb) in length (Fig. 1). 
The genome contains a 5′ untranslated region (5′UTR) 
of ~ 100 nucleotides with a a type-I 5′ cap, a single open 
reading frame of ~ 10 kb, and a 3′UTR of ~ 420 nucleotides 
[52]. Both the 5′ and 3′UTRs contain a number of RNA 
structure elements and primary sequence motifs, essen-
tial for stabilising alternative linear and cyclised genome 
conformations and initiation of negative-strand replication 
(reviewed for example in [53]). The open reading frame 
encodes a single polyprotein, which is co- and post-transla-
tionally cleaved into the capsid (C), the precursor membrane 
(prM) and the envelope protein (E), as well as seven non-
structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B 
and NS5) involved in replication, assembly, and antagonis-
ing the innate immune response of the host [54].
The general life cycle of a virus is shown in Fig. 2. In 
brief, ZIKV enters the host-cell via receptor-mediated endo-
cytosis [55], through candidate receptors AXL and Tyro3 
[56–59]. Following endosome acidification and subsequent 
conformational changes to the E protein, ZIKV RNA is 
released into the host cell and is translated as a polypro-
tein—that is subsequently cleaved by viral and host-cell pro-
teases, into the structural and non-structural proteins [54]. 
The non-structural proteins are essential for formation of 
the virus replication complex and subsequent ZIKV genome 
replication and translation. For examples, among other func-
tions, non-structural protein 5 (NS5) has both viral RNA 
dependent RNA polymerase and methyltransferase activity, 
responsible for both replication and capping of the ZIKV 
genome respectively. The capsid protein packages genomic 
viral transcripts and along with the other structural proteins 
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assemble on the surface of the ER as immature non-infec-
tious virions. Subsequent maturation, during transportation 
through trans-Golgi apparatus, involves cleavage of prM by 
the host protease furin into the pr peptide and M protein 
before release of infectious virions from the cell by exocy-
tosis [60, 61].
How does Zika cause microcephaly?
Primary microcephaly may be caused by depletion of the 
founder population of radial glia (neural stem cells found in 
the developing foetal brain), caused either by mass cell death 
or premature differentiation [62]. There have previously 
been cases reported of neurodevelopmental brain malfor-
mations, including microcephaly, associated with infections 
from various other viruses such as cytomegalovirus (CMV), 
rubella virus, West Nile Virus (WNV), Human Immunodefi-
ciency Virus (HIV), herpes simplex virus and chikungunya 
[63–68]. These mechanisms are thought to bear similarities 
to those observed with ZIKV and this will be discussed fur-
ther in this report.
Initial infection
ZIKV is primarily spread via Aedes spp. mosquitoes, 
predominantly A. aegypti but increasingly A. albopic-
tus (Fig. 3). The virus is transmitted through the bite of 
an infected mosquito, but may also be transmitted sexu-
ally or through blood transfusions [69]. Within an urban 
Fig. 1  The Zika virus genome consists of 10.8 kb, coding for three structural proteins—capsid (C), precursor of membrane (prM) and envelope 
(E)—and seven non-structural proteins—NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5
Fig. 2  ZIKV replication cycle. Virus enters the cell through receptor-
mediated endocytosis, RNA/protein synthesis is carried out, leading 
to genome replication and then assembly of the infectious virus par-
ticles, and finally the virus is released from the cell and goes on to 
infect a new cell
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transmission cycle, mosquitoes are commonly infected fol-
lowing a blood meal from a ZIKV viremic individual, how-
ever vertical transmission via infected A. aegypti eggs has 
also been observed [70].
It is suggested that only 20% of ZIKV infections result in 
a symptomatic phenotype [71]. However, when symptoms 
do develop following infection, they tend to be mild and self-
limiting, and include fever, maculopapular rash, joint-pain, 
headache and conjunctivitis or red eyes [71]. These symp-
toms are non-specific and are similar to infections caused by 
other arboviruses such as dengue or chikungunya viruses, 
consequently diagnosis of ZIKV infection upon clinical 
presentation alone is almost impossible. More severe neu-
rological symptoms such as Guillain–Barré syndrome have 
also been described but are comparatively rare [45, 69, 72].
Infection with ZIKV results in downregulation of vari-
ous genes that are involved in cell cycle-related pathways, 
e.g. mitosis and cell cycle phase genes [73]. One of these 
cell cycle-related genes, CENPF [74], encodes a kinetochore 
protein. This protein is essential for the proper alignment 
of fully formed chromosomes during mitosis, as well as 
recruiting additional proteins that, collectively, play a part in 
spindle-pole formation. Primary microcephaly phenotypes 
have previously been shown to be affected by downregula-
tion of genes involved in various stages of the cell cycle 
including centrosome maturation and spindle-pole formation 
[34]. This may suggest that ZIKV could interact with genes 
previously implicated in MCPH.
In addition to affecting genes involved in the cell cycle, 
ZIKV infection has been shown to significantly downregu-
late expression of genes associated with neural stem cells, 
neuronal cell types, and oligodendrocytes. As well as this 
downregulation, infection has been shown to upregulate 
certain genes, for example those associated with astrocyte 
differentiation as well as antiviral genes such as Toll-Like 
Receptor 3 (TLR3), Viperin and CCL2 [75]. This data sug-
gests that, during infection, ZIKV targets several neural cell 
types, while also inducing differentiation of astrocytes and 
promoting TLR3 in order to initiate cellular disorder.
Evasion of immune response
Following virus infection, human cells initiate the pro-
duction of small chemical messenger molecules known as 
cytokines. Critical cytokines are the initial response to viral 
infection, the first being interferons. The type I interferons 
α and β are produced by all nucleated cells in the body, 
particularly plasmacytoid dendritic cells. They inhibit viral 
replication by inducing an antiviral state through the expres-
sion of interferon-stimulated genes (ISGs) [76]. Examples 
of ISGs include double stranded (ds) RNA activated protein 
kinase (PKR), whose activation results in the inhibition of 
protein synthesis and therefore of new virus particles, and 
Oligoadenylate synthetase, whose activation by dsRNA 
results in the degradation of viral RNA. IFNs act as the ini-
tial response to infection, leading to the activation of natural 
killer cells and MHC Class I antigen presentation.
As with many viruses, Flaviruses have evolved various 
strategies in order to escape the immune response exhibited 
by the host cells, often involving the non-structural proteins 
encoded in their genomes. These mechanisms include inhib-
iting IFN, complement system, natural killer cells, and T and 
B cell responses [55]. For example, infection with dengue 
virus has been shown to inhibit expression of IFNα, even 
following stimulation by strong inducers of type I IFN [77].
ZIKV infection has been shown to be able to be restricted 
by several ISGs [78]. Studies have found that ZIKV NS5 
protein inhibits type I IFN signalling by binding to and 
degrading STAT2, an essential transcription factor involved 
in type I IFN-mediated signalling [79, 80]. Although the 
NS5 protein appears to play a role in targeting type I IFN 
signalling, it is unknown if this interaction is cell-type 
dependent. More research needs to be done to establish the 
effect of the virus on STAT expression, phosphorylation and 
degradation in cell types that are known to be involved in 
the pathogenesis of the virus. Further to signalling regula-
tion activity by the NS5 protein, the NS1 and NS4B proteins 
have been shown to inhibit RIG-I-like receptor signalling, 
supressing type I IFN induction [81].
These findings suggest that the non-structural proteins 
encoded by the ZIKV genome are used to evade the host 
Fig. 3  The ‘story of infection’. Simple representation of the events 
leading up to the development of foetal microcephaly. Source some 
images from https ://www.cdc.gov/ncbdd d/birth defec ts/image s/micro 
cepha ly-compa rison -500px .jpg
 Molecular Biology Reports
1 3
immune system by inhibiting pathways that lead to the 
induction of type I IFN and ISGs. Clearly, the virus has 
evolved several mechanisms allowing the interference of 
type I IFN signalling, a crucial step permitting infection of 
the host mother, and hence infection of the foetus that leads 
to microcephaly.
As observed in other viruses, it is likely that ZIKV non-
structural proteins are responsible for similar roles. For 
instance, the NS1 protein of dengue virus is thought to 
inhibit the innate antiviral immune response by activating 
TLR4 and interfering with TLR signalling [82, 83]. The NS1 
protein of WNV has likewise been shown to inhibit TLR3-
induced antiviral effects [84]. Furthermore, in a more dis-
tantly related member of the Flaviviridae family, Hepatitis 
C Virus (HCV) NS2 protein, a transmembrane polypeptide, 
has been implicated in playing a role in the inhibition of 
apoptosis [85], as well as in cell growth and interference 
with cell cycle regulation, all roles that may be beneficial 
for replication of the virus in host cells [86].
Likewise, NS2A, NS2B, NS4A, NS4B and NS5 proteins 
of dengue virus, NS3/4A, NS4B and NS5A proteins of HCV, 
and the NS4B protein of WNV have all been shown or sug-
gested to be involved in immune evasion [87–95].
Cellular entry
Following transmission to the human host, ZIKV is likely 
to enter target cells through cellular receptors as with other 
Flaviviruses. However, this has not yet been studied in detail 
and the specific mechanism for ZIKV entry is not yet clear.
Flaviviruses are known to enter host cells through the 
process of endocytosis following the interaction of the E 
glycoprotein with host cell surface receptors and attachment 
factors [77, 96, 97] (Fig. 4). Differential expression of these 
molecules determines the cellular tropism of the virus [98].
It is believed that Flaviviruses use at least two types of 
molecule in the processes of receptor recognition and attach-
ment: attachment factors and primary receptors. Attachment 
factors are thought to concentrate/recruit virus particles to 
the surface of the cell, allowing faster entry, and primary 
receptors are used to bind virions, directing them to the 
endocytic pathway. Specifically, C-type (calcium dependant) 
lectin receptors, phosphatidylserine receptors, TIM (T-cell 
immunoglobulin and mucin domain) and TYRO3, AXL and 
MER (TAM) receptors have all been indicated to be involved 
in cellular entry of Flaviviruses [58].
Several studies have suggested glycosaminoglycans 
(GAGs), such as heparan-sulphate proteoglycans or synde-
cans, as being initial host-cell attachment factors for the Fla-
viviruses [99–104]. GAGs are long, unbranched, sulphated 
Fig. 4  Mechanism of viral entry, and subsequent actions within the cell, including proposed functions of non-structural proteins ultimately 
resulting in microcephaly
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polysaccharides with a repeating disaccharide unit. They are 
found linked to core proteins which are attached to cellular 
surfaces (proteoglycans) and are primarily exposed on the 
surface of cells in all tissues [105].
Due to their position on the cell surface, GAGs are an 
ideal candidate, easily accessible for viral attachment. The 
electrostatic interaction caused by the difference in charge 
between the positive residues of the E glycoprotein and the 
negative sulphate groups exposed on the polysaccharide 
appears to be the primary interaction allowing the attach-
ment of the virus particle [99]. In this instance, the main role 
of GAGs is as attachment factors allowing the concentration 
of the Flavivirus particles at the surface of target cells, facili-
tating their interaction with primary entry receptors such as, 
in the case of ZIKV, the candidate receptor AXL [99–103]. 
It is likely that there are various cellular attachment factors 
and receptors that allow the concentration and entry of these 
viruses into cells, and that these receptors can function inde-
pendently of each other, meaning that even by blocking one 
receptor the virus may still manage to enter the host cells via 
an alternative mechanism.
In their study on the biology of the ZIKV, Hamel et al. 
[98] showed that virus entry is mediated by several cellu-
lar factors such as DC-SIGN, AXL, Tyro3 and TIM-1. It 
seemed that some of these factors may not contribute to the 
infection itself, but rather that they co-operate with other 
factors/receptors to cause an additive effect. For example, 
TIM-1 made little contribution to the entry of the virus, but 
its expression increased the efficacy of viral entry mediated 
by the AXL receptor. This suggests that TIM-1 may act as 
an attachment factor, binding viral particles and transfer-
ring them to the AXL receptor, allowing internalisation of 
the virus. In this case, the TIM-1 receptor would concen-
trate virions on the cell surface, hence easing their interac-
tion with the AXL receptor and facilitating viral infection. 
However, the exact role of the TIM and TAM receptors in 
the infection of ZIKV is not well understood and requires 
additional research.
AXL belongs to the Tyro AXL MER (TAM) family of 
receptors. The TAM family are a group of tyrosine kinase 
receptors, known to be involved in the processes of clearing 
apoptotic cells and regulating the innate immune response 
[106]. AXL mRNA has been found to be present in human 
neural progenitor cells (NPCs), the cells which differenti-
ate to produce the neurons and glia of the nervous system 
during embryonic development, as well as other brain cells 
such as radial glial cells, microglial cells and astrocytes [57]. 
Poorly susceptible cells have been shown to demonstrate 
sensitivity to ZIKV infection following the expression of 
various known Flavivirus entry factors, including AXL [98]. 
The same study also found that, by blocking or silencing the 
AXL receptor, in vitro infectivity is reduced by up to 90% 
in cultured fibroblasts and alveolar epithelial cells. These 
results suggest that the AXL receptor is a main contributor 
in the cellular entry and infection process of ZIKV.
It has been suggested that ZIKV targets in vitro-derived 
progenitor cells as opposed to immature neurons [73]. This 
has been supported by Nowakowski et al. [57], who reported 
that the AXL receptor is highly expressed in radial glia, with 
78/96 radial glia displaying expression greater than 6 log2 
normalised read counts. These results are in contrast with 
the limited expression shown by TYRO3 (5/96 radial glia). 
Radial glia are the neural stem cells of the foetal cerebral 
cortex in humans. A large abundance of the AXL receptor 
in these cells may provide a suggestion as to why these cells 
appear to be particularly susceptible to infection by ZIKV. 
The disruption of radial glia may explain how ZIKV causes 
microcephaly—by interrupting the growth of the cerebral 
cortex in the foetus.
In addition to its role as a viral entry factor, AXL sig-
nalling has been shown to suppress the innate immune 
response [107]. The receptor’s kinase domain has been seen 
to enhance infectivity of dengue virus following cell entry 
[108]. ZIKV may similarly activate AXL signalling upon 
binding to the AXL receptor, suppressing the innate immune 
response and therefore enhancing the ability of the virus to 
establish a persisting infection in the host and prevent viral 
clearance [109]. It has been suggested that the interaction 
between the virus and the AXL receptor on human astro-
cytes and the subsequent subversion of the host immune 
response is an important contributing factor leading to 
pathogenesis [56].
However, other studies indicate that the AXL receptor 
may not be the main entry receptor used by this virus. A 
study by Hastings et al. [110] concluded that TAM receptors 
were not required for cell entry and viral infection in mice. 
This study performed comparative infection studies in wild 
type and in TAM receptor knockout mice. The study found 
that TAM receptors were not required for the entry of ZIKV 
through trans-placental, vaginal, subcutaneous, or intracra-
nial routes of infection. They also suggested that cellular 
targets in the brain and placenta are similar, regardless of 
whether TAM receptors are present or not. This indicates 
that, in mice, ZIKV infection is not dependant on the pres-
ence of TAM receptors. However, it is worth noting that 
these results may suggest that there are several viral entry 
receptors facilitating infection of cells by ZIKV. As dis-
cussed previously, C-lectins, phosphatidylserine receptors 
and TIM-1 receptors could all be implicated in virus cellular 
entry, which may be why the virus is still able to infect target 
cells in the absence of TAM (AXL) receptors.
Initial cellular targets
Given the fact that ZIKV is transferred to humans mainly 
through the blood-feeding process of mosquitos, it is 
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understandable to think that initial target cells for the virus 
are likely to be localised to the skin layers, i.e. the dermis 
and the epidermis, where the virus is deposited. Skin fibro-
blasts have previously been recognised as being highly per-
missive targets for arboviruses [111]. ZIKV has been shown 
to infect numerous cell types, including cells of the dermis 
and epidermis, dendritic cells, placental macrophages, and 
neural progenitor cells [57, 73, 98, 112].
In a study by Hamel et al. [98], active ZIKV replication 
was demonstrated in infected skin fibroblasts, found in the 
dermis layer. Infection of these cells resulted in the presence 
of high RNA copy numbers and an increase in the number 
of ZIKV particles produced over time. This study also found 
that, upon ZIKV infection, keratinocytes, cells found in the 
epidermis, showed the presence of cytoplasmic vacuolation 
and pyknotic nuclei in the stratum granulosum—indica-
tors of cells which are undergoing apoptosis. In addition to 
dermal fibroblasts and epidermal keratinocytes, it was also 
shown that dendritic cells, another cell type present in skin, 
are permissive to ZIKV infection. Induction of cell death in 
these skin cells could be a mechanism which allows the virus 
to divert the initial antiviral immune response, allowing 
easier entry of the virus into the host and, in the context of 
this report, ultimately leading to entry into the foetal brain. 
Interestingly, replication of ZIKV in human skin fibroblasts 
was shown to be enhanced by cellular autophagy.
Some studies have reported that the early cellular targets 
of the virus appear to be astrocytes [75, 113]. Astrocytes 
are some of the first responders to viral infections. They are 
characteristically star-shaped glial cells which are found in 
the brain and spinal cord, an important component of the 
central nervous system. Astrocytes perform an assortment of 
tasks, including axon guidance, synaptic support and control 
of the blood brain barrier. They have roles in maintaining 
synapse homeostasis, regulating neuronal signalling, deter-
mining the outcome of endogenous neural precursors, and 
protecting neurons from the damage of oxidation [114].
The significance of astrocytes being an early target for 
the virus may be due to their interaction with the vascular 
system. This would allow the virus to reach the target organ 
more rapidly. This was demonstrated in a study by Kozak 
et al. [115] during which the virus was detected in several 
brain regions as early as 4 days following infection. This 
study found that miRNAs and mRNAs are dysregulated in 
astrocytes infected with the virus. Globally, miRNAs were 
downregulated. However, the small number of miRNAs 
that were upregulated appeared to be correlated with host 
pathways associated with infection of the virus. This would 
suggest that the regulation of astrocyte miRNA is involved 
in allowing the virus to infect the human host, and may be 
responsible for the subversion of the host immune response.
Vertical transmission: crossing the placental barrier
Zika virus RNA has been detected in placental and neural 
tissue in infected humans, as well as in amniotic fluid and 
brain tissues from new-borns who had been diagnosed with 
foetal microcephaly [116–119]. These findings suggest that 
the mechanism by which ZIKV infects the foetus is by dis-
rupting and passing through the placental barrier during ver-
tical viral transmission. Subsequently, various reports have 
established that ZIKV has the ability to cross the human 
foetal-placental barrier in order to infect the developing 
brain and nervous system [109, 118, 119].
Few viruses are known to cross the placental barrier. 
One such virus is cytomegalovirus (CMV), a dsDNA virus 
belonging to the Herpesvirida family. Although unrelated 
to ZIKV, infection with CMV causes similar neurodevelop-
mental brain abnormalities [67, 120]. The neuroinvasive-
ness of CMV is mediated by various entry factors, such as 
EGFR and integrins, which are particularly highly expressed 
in radial glia and neural stem/progenitor cells [121]. Higher 
expression of these entry proteins, particularly of β1 integrin 
in this case, determines the initial susceptible cell population 
in the brain. It is therefore plausible to theorise that the Zika 
virus infects cells with high expression of the entry receptor 
AXL, such as neural progenitor cells.
Rubella is another virus that is able to cross the placen-
tal barrier, with infection of the placenta occurring during 
maternal viraemia. This infection results in areas of necrosis 
that are focally distributed within the epithelium of chori-
onic villae, as well as in the endothelial cells of its capillar-
ies [96].
However, this behaviour has not previously been asso-
ciated with Flaviviruses. For example, congenital acquisi-
tion of West Nile Virus has previously been investigated, 
but most infants were born at term and without complica-
tions that could be attributed to WNV infection, suggesting 
that the virus was unable to cross the placental barrier [65, 
122]. Furthermore, there are an estimated 390 million cases 
of Dengue infection per year [123], but the virus has not 
been shown to be able to cross the placental barrier and 
there have been no reported cases of associated congenital 
microcephaly.
There have been various proposed mechanisms by which 
ZIKV can enter the foetal compartment in order to gain 
access to foetal target cells. Firstly, it was proposed that the 
virus would be carried by viraemia from the maternal blood 
stream into the maternal blood space between the developing 
placenta and the decidua, or the uterine lining which forms 
the maternal part of the placenta [124].
Primary placental cells, such as amniotic epithelial cells 
that proliferate in the amniotic membranes, were shown 
to be susceptible to infection with ZIKV. The virus was 
seen to grow well in these cells, particularly in those from 
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mid-gestation compared to those from late-gestation [124]. 
This suggests that infection of a pregnant woman during the 
mid-gestational phase, while the foetus is growing, would 
allow the transmission of the virus to the foetus through 
the close contact of the parietal decidua with the anmio-
chorionic membranes. The maternal blood may infect the 
trophoblasts in these membranes, allowing the virus to cross 
into the foetal compartment and hence directly infect the 
growing foetus. However, it has been suggested that primary 
human placental trophoblast cells from full-term placentas 
are in fact refractory to infection with ZIKV due to Type 
III Interferon production [125]. Therefore, this route would 
require further investigation including control of gestational 
age to investigate whether these cells are always resistant to 
infection or if resistance is developed with gestational age 
of the foetus. This hypothesis is supported in a study by 
Bayer et al. [125] which suggested that the less differenti-
ated trophoblasts present in the first trimester of pregnancy, 
along with extra-villous trophoblasts, are more permissive 
to infection when compared to villous trophoblasts present 
during late stages of pregnancy.
Many studies have been conducted investigating the cells 
infected by ZIKV during its crossing of the placental bar-
rier. It has been shown that ZIKV has the ability to infect 
human placental macrophages, also known as Hofbauer cells 
[112, 117, 125]. Hofbauer cells are a heterogeneous, foetal 
population of macrophages residing in the chorionic villus, 
a functional unit of the placenta. These cells are associated 
with a wide range of functions that are crucial in a success-
ful pregnancy, such as immune regulation, placental mor-
phogenesis, transfer of ions and serum proteins across the 
maternal-foetal barrier, and control of stromal water con-
tent. Imbalances in the homeostasis of Hofbauer cells are 
associated with placental pathologies that involve infections, 
inflammation, and inadequate development of the placenta 
[126].
Bhatnager et  al. [117] indicated that Hofbauer cells, 
which can reach foetal blood vessels, may be responsible 
for the dissemination of ZIKV into the foetal brain, par-
ticularly in early pregnancy as this is when Hofbauer cells 
are most abundant in the placenta. Bayer et al. [125] dem-
onstrated that ZIKV infects and primarily replicates within 
Hofbauer cells in vitro. Interestingly, Dengue virus has also 
been shown to target macrophages to aid in its dissemina-
tion [127]. These findings suggest that Hofbauer cells may 
be significant targets for ZIKV, facilitating transfer or dis-
semination into the foetal brain, as demonstrated in Fig. 5.
In addition to the infection of these placental mac-
rophages, it has been shown that ZIKV is able to replicate in 
anchoring villi and basal decidua from first-trimester placen-
tas. This would allow prolonged viraemia during the earlier 
stages of development, and would lead to trans-placental 
transmission [124].
Infection of foetal cells
Nowakowski et al. [57] proposed that, after breaching the 
foetal-placental barrier, the virus reaches the brain of the 
developing foetus by haematogenous spread, or via the cer-
ebrospinal fluid. Once at the target site, it is hypothesised 
that radial glia cells are the first target cell population with 
the highest AXL expression. Zika would then enter these 
cells, either through their contact with blood vessels, or via 
their direct contact with the cerebrospinal fluid through their 
apical end-feet.
Neural progenitor cells and radial glia have been widely 
accepted in recent literature as being the major cellular target 
of ZIKV in the developing foetal brain. NPCs are similar to 
stem cells which differentiate to produce the neurons and 
glia of the nervous system, critical during brain develop-
ment of foetuses.
Radial glia span the width of the cortex in the developing 
central nervous system, serving as primary progenitor cells 
that are capable of differentiating into neurons, astrocytes, 
and oligodendrocytes [128]. As the virus targets these cor-
tex spanning cells, this may explain why infected foetuses 
display the phenotype known as microcephaly, whereby the 
brain is smaller than usual (i.e. three or more standard devia-
tions below the mean).
Research has suggested that ZIKV can replicate in both 
mouse astroglial cells and in neurons [116]. The viral RNA 
has been detected in human placental and neural tissue [118, 
119]. It has also been suggested that the virus is able to 
infect human neural progenitors as well as mature neurons, 
and increase expression of apoptotic markers. Infection has 
additionally been shown to impair growth of human neural 
stem cells and brain organoids [73, 129].
The mammalian target of rapamycin (mTOR) is a serine/
threonine kinase, a component of two protein complexes 
that are functionally distinct from each other, known as 
mTORC1 and mTORC2. Each complex responds to varied 
Fig. 5  ZIKV crosses the placental barrier, infecting Hofbauer cells 
which then allow the virus to transfer to the foetus through foetal 
blood vessels, particularly in early pregnancy
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environmental stimuli and has different regulatory properties 
and cellular activities [130].
The Akt-mTOR signalling pathway plays a crucial role 
in regulating various processes in NPCs, including cellu-
lar development, proliferation, survival and inhibition of 
autophagy [131]. This pathway has been shown to be crucial 
in establishing proper neuronal architecture, and in regulat-
ing neural specification and function [132]. A study by Liang 
et al. [133] suggested that the NS4A and NS4B proteins 
encoded in the ZIKV genome cooperate in order to inhibit 
the activation of Akt, thus inhibiting downstream signalling 
via this pathway in NPCs. Preliminary studies have indi-
cated that the NS4A and NS4B protein complex is able to 
inhibit PI3K (phosphatidylinositide 3 kinase), the upstream 
activator of Akt, thereby terminating the Akt-mTOR signal-
ling cascade [134]; however, this phenomenon is not well 
understood and requires further investigation. Likewise, a 
correlation between Dengue virus (DENV) infection and 
decreased activity of mTORC1 has been found [135]. This 
was inversely correlated to lipophagy induction, which was 
in turn said to promote viral replication. These studies sug-
gest that Flaviviruses are able to disrupt the mTOR pathway 
in infected cells, with the result (i.e. inhibition of neurogen-
esis or induction of autophagy or lipophagy) depending on 
the target cell type of the individual virus.
In contrast, a related Flavivirus, West Nile Virus (WNV), 
has been seen to upregulate the mTOR pathway through 
a PI3K-dependent mechanism. Shives et al. [136] demon-
strated that infection of serum-starved mammalian cells with 
WNV leads to activation of mTOR Complex 1, which is 
involved in governing diverse anabolic and catabolic pro-
cesses including protein synthesis and autophagy. Activating 
this complex allows the support of viral growth and protein 
expression within the host cell. This mechanism was proven 
to be crucial for viral replication, evidenced by a reduction 
in WNV growth following pharmacological inhibition of 
PI3K. Shives et al. concluded that TORC1 supports pro-
tein synthesis of Flavivruses and subsequently supports the 
growth of WNV. Blocking of apoptosis by a PI3K-dependant 
mechanism has similarly been observed following viral entry 
of DENV-2 and JEV, but pharmacological blocking of PI3K 
had no effect on their viral replication [137].
It is evident that the mTOR signalling pathway is impor-
tant in Flavivirus pathogenicity, with roles in controlling 
apoptosis, induction of autophagy and viral replication, but it 
is unknown why some Flaviviruses upregulate the pathway 
whereas others, namely ZIKV, downregulate the pathway.
A key factor which separates ZIKV from other related 
Flaviviruses is its tissue and cell tropism. ZIKV preferen-
tially infects neural progenitor cells of the embryonic brain, 
resulting in their apoptotic cell death, with the ability to also 
infect mature neurons to a lesser extent [73, 138, 139]. Con-
versely, related Flaviviruses such as WNV and JEV, which 
are responsible in causing encephalitis post-natally, pri-
marily target mature neurons in infected adults [140–142]. 
Interestingly, a study by Brault et al. [143] investigated the 
cell tropism for ZIKV, WNV and DENV-4 (Dengue Virus 
Serotype 4) in mouse developing neocortex and found that 
this tissue supported viral replication of ZIKV and WNV but 
not of DENV-4. It was further shown that only infection with 
ZIKV was able to halt cell cycle progression of neural stem 
cells, whereas WNV infection did not. This would indicate 
that the ability of ZIKV in causing microcephaly is largely 
due to its infection of NPCs and subsequent impairing of cell 
cycle progression, followed by the induction of apoptosis of 
these cells [138], hence reducing the pool of cortical neural 
progenitors and consequently reducing the size of the foetal 
cortex and brain.
Infection of various cells of the brain has been supported 
in many studies. Van den Pol et al. [113] showed that, fol-
lowing peripheral inoculation of developing new-born nor-
mal mice, neural glial cells were substantially infected as 
an initial target. This was particularly seen in cells with a 
morphology and GFAP (glial fibrillary acidic protein) anti-
gen expression aligning with that of astrocytes. Infected 
isolated astrocytes were found throughout the brain, sug-
gesting a widespread occurrence of infected astrocytes and 
hence many penetrations of ZIKV into the developing brain. 
This could indicate that not only do astrocytes show the first 
signs of infection, but they may also be used as a mechanism 
of further amplifying and distributing infectious viral parti-
cles to neighbouring neurons and glia. Interestingly, CMV 
has also been shown to have a tendency to target astrocytes 
[144].
In addition to targeting of astrocytes, recent work has 
also explored the targeting of human neural progenitor 
cells (hNPCs), the cells which differentiate to produce the 
neurons and glia of the nervous system during embryonic 
development, and why these cells appear to be exceptionally 
vulnerable to infection with the virus.
It has been widely shown that ZIKV is lethal to human 
neural stem/progenitor cells [57, 73, 129, 145]. These cells 
express the transcription factor Sox2, a critical factor for 
initiating neural induction and maintaining the properties 
displayed by neural progenitor stem cells throughout their 
differentiation [146]. One study suggested that ZIKV may 
cause microcephaly through the depletion of the founding 
population of NPCs expressing Sox2, which, as previously 
discussed, are highly susceptible to ZIKV infection [147].
Tang et al. [73] showed that human NPCs are highly 
susceptible to ZIKV infection in vitro, with the infection 
reaching 65–90% of the cells within 3 days of inoculation. 
Other cells such as human embryonic stem cells and human 
induced pluripotent stem cells were able to be infected, but 
the infection did not spread further than the cells at the col-
ony edge. This establishes that hNPCs, a population of cells 
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that contribute to the developing embryonic brain, act as a 
direct target for ZIKV. The study concluded that infection 
of hNPCs with ZIKV leads to attenuated population growth. 
This was said to be due to caspase 3-mediated apoptosis 
and dysregulation of the cell cycle, induced by viral infec-
tion. Hanners et al. [139] also suggested an apoptotic mode 
of action as, during their study, they noted the presence of 
pyknotic nuclei in infected hNPCs, typically coupled with 
ZIKV antigen and activated caspase 3. In addition, this 
study found that ZIKV persistently replicates in hNPCs, 
with one cell line continuing to produce virus particle for 
up to 28 days post infection. This persistent virus produc-
tion is supported in other studies; for example, Mlakar et al. 
[109] observed ZIKV particles present in the brain tissue of 
foetuses 19 weeks after presumed maternal infection.
In vitro, infection of NPCs with ZIKV leads to impaired 
proliferation of NPCs and apoptotic cell death [147]. In 
mouse models, it has been shown that the virus targets 
NPCs, altering cell division and inducing cell death, and 
reducing the pool of cortical neural progenitors [74, 148]. 
This leads to brain developmental defects, including micro-
cephaly, in infected mice.
Further research indicating NPCs as viral targets was 
carried out during the investigation of neurodevelopmental 
RNA-binding protein Musashi-1 (MSI1). MSI1 was shown 
to promote UTR-driven translation of the ZIKV genome 
in vitro, showing that the protein interacts with the genome 
of the virus in order to aid or enable its replication and there-
fore it promotes the viral life cycle [149]. Unsurprisingly, 
MSI1 was found to be highly expressed in neural progeni-
tors found in the embryonic brain of human foetuses, while 
being absent in mature neurons. Furthermore, this protein 
has been shown to be mutated in individuals suffering from 
recessive primary microcephaly. This suggests that MSI1 is 
a key protein in both the infection period of ZIKV, as well 
as in the development of foetal microcephaly.
Zika-encoded NS2A has been found to disrupt mamma-
lian cortical neurogenesis and decrease cell proliferation 
by degrading the adherens junction proteins that form the 
adherens junction complex [150]. Also, the capsid protein 
has been shown to interact with mouse-double-minute-2 
(MDM2) homolog, a protein involved in the regulation of 
p53. This lead to the activation of the p53-mediated apop-
tosis pathway and hence the death of infected neural cells 
[151]. Interestingly, the same study found that synthetic 
mimics of the ZIKV capsid protein were able to induce cell 
death both in vitro and in vivo. This provides an important 
insight into the role of the virally encoded proteins in infec-
tion and causation of the microcephalic phenotype.
It has been shown that ZIKV persistently infects vari-
ous trigeminal and dorsal root sensory neurons. Conversely, 
autonomic sympathetic and parasympathetic neurons were 
shown to be non-permissive to infection [152]. This is 
supported by the finding that cells of the peripheral nervous 
system are much less susceptible to infection than cells of 
the central nervous system (CNS), with all major CNS cell 
types being susceptible to infection, particularly oligoden-
drocytes [153].
This evidence amounts to a consensus that the main tar-
get of the Zika virus once it has reached the foetus in utero 
is neural progenitor/stem cells. The fact that these cells 
have high expression levels of the proposed entry receptor, 
AXL, may be critical to the tissue specificity of the viral 
target. The degeneration of this target cell population via the 
various proposed mechanisms may explain the fact that the 
patients with microcephaly have brains three or more stand-
ard deviations below the normal size. It is already known 
that the size of the cerebral cortex is determined by the rate 
at which neurons and glial cells are produced [154]. It would 
therefore be plausible to assume that microcephaly in these 
infected foetuses is caused by cell death and dysregulation 
in neural progenitor and glial cells. However, questions still 
remain concerning why not all foetuses develop microceph-
aly, the exact mechanism behind the susceptibility of neural 
progenitor cells, the exact receptors involved in viral entry 
and the role of the immune response.
Discussion
In this report we have provided an overview of our emerging 
insight into the link between Zika virus infection of pregnant 
women and the development of microcephaly in foetuses.
The virus infects the adult human host predominantly 
through the bite of an infected Aedes mosquito. In most 
cases, infected adults are asymptomatic, but some infected 
individuals may present with fever, maculopapular rash, 
joint pain, headache or conjunctivitis, or, in severe cases, 
may develop Guillain–Barré syndrome.
The virus must overcome the immune response of the 
host in order to replicate and sustain infection within host 
cells, before crossing the placental barrier and moving to the 
target site of the foetal brain. It appears as though ZIKV has 
evolved various mechanisms to do this.
Firstly, it has been shown that the virus is able to upregu-
late and downregulate various genes, mostly those involved 
in the cell cycle, differentiation (for example astrocyte dif-
ferentiation), apoptosis and antiviral pathways. Most of the 
genes affected by the virus are expressed predominantly in 
neural cell types such as neural progenitor cells and oligo-
dendrocytes. Interestingly, some genes with altered expres-
sion as a result of ZIKV infection are also implicated in 
MCPH. This gives rise to the question as to whether the 
virus is able to interact with genes that are already known to 
be associated with the congenital microcephaly phenotype.
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Mechanisms of evasion of the host immune response 
are largely encoded within the ZIKV genome in the form 
of the non-structural proteins produced following cleav-
age of the polyprotein. Currently, the NS5 protein has been 
shown to inhibit type I interferon signalling by degrading the 
transcription factor STAT2, and NS1 and NS4B have been 
shown to inhibit RIG-I like receptor signalling, suppressing 
type I IFN induction. It is likely that other non-structural 
proteins encoded in the genome also have further roles to 
play in the immune evasion strategies of the virus, as with 
related viruses such as Dengue, HCV and WNV, however, 
these have not yet been firmly established.
In order to reach the cellular targets in the foetal brain 
(Fig. 6), the virus must survive and replicate within ini-
tial cellular targets such as skin cells, and ZIKV has been 
shown to infect cells of the dermis and epidermis, e.g. skin 
fibroblasts.
There have been various receptors proposed to be the 
entry receptors for ZIKV. The main candidate receptors 
are AXL and Tyro3. It is thought that the virus attaches 
to factors (such as polysaccharides) on the cell surface via 
its envelope (E) protein. This allows the virus particles to 
be concentrated at the cell surface, thus facilitating their 
interaction with entry receptors such as AXL. Although the 
evidence in support of AXL being the major entry recep-
tor is abundant, one study conducted in mice did find that 
the presence or absence of TAM receptors did not seem 
to impact on viral infection. However, this study may just 
indicate that AXL is not the sole receptor responsible for cell 
entry of the virus, and that other receptors may also carry 
out this function. At this point, it is still thought that AXL is 
the main receptor implicated in virus entry, especially due 
to the high expression levels in cells that are highly targeted 
by the virus such as neural progenitor cells.
Following initial infection, it is likely that the virus 
reaches the placenta through viraemia. When at the placen-
tal barrier, the virus must cross in order to infect the foetus 
and be detected in foetal tissue and amniotic fluid, though 
the exact mechanism has not yet been established. It has, 
however, been shown that the virus is able to infect Hofbauer 
cells (placental macrophages) and amniotic epithelial cells. 
Transmigrating ZIKV-infected monocytes may also act as 
“Trojan horses” for disseminating the virus and enabling its 
penetration through endothelial barriers [156].
Once across the placental barrier, the virus then reaches 
its target population, neural progenitor cells. Here, the virus 
disrupts these and related cells, such as radial glia. This may 
be through inducing autophagy and apoptosis, disrupting 
cellular development or disrupting differentiation and pro-
liferation. Neural progenitor cells have been shown to be 
highly susceptible to ZIKV infection. These cells are those 
which differentiate to produce cortical neurons. The fewer 
neural progenitor cells available, the fewer cortical neurons 
produced and therefore the smaller the cerebral cortex and 
the smaller the brain, resulting in microcephaly.
Fig. 6  Summary of mechanisms causing impaired brain development 
and a microcephalic phenotype following infection with Zika virus. 
ZIKV enters through skin cells, eventually reaching the target popu-
lation of neural progenitor cells with varying effects. Source figure 
adapted from [155]
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Conclusions
Following the Public Health Emergency of International 
Concern declaration by WHO regarding ZIKV in February 
2016, much progress has been made in terms of understand-
ing the mechanism by which the virus infects human cells 
and leads to hampered brain development and microcephaly 
in foetuses. Evidence from varying sources investigating 
multiple model systems all consistently point to the con-
clusion that: vertical transmission of ZIKV from pregnant 
females to their unborn foetuses via the trans-placental route 
targets neural progenitor cells, and other neuronal cells such 
as radial glia, in the developing brain, causing death, apop-
tosis and decreased proliferation of these cells, and resulting 
in impaired brain development and therefore a microcephalic 
phenotype.
Unanswered questions
Despite the advancements made already in understanding 
the impact of ZIKV infection, there are still many questions 
to be answered before its mechanisms are fully understood, 
allowing the possibility to create an effective vaccine or 
treatment for infection.
Firstly, the question remains as to why only a small num-
ber of foetuses born of infected mothers display microceph-
aly. Why aren’t all foetuses affected? Is infection strain-spe-
cific or perhaps specific to different human populations? Are 
there mutations within the ZIKV genome that are required 
in order to cause microcephaly? Or is this to do with the 
mother’s own immune system and therefore the ability of the 
virus to cross the placental barrier? Are there geographical 
factors, such as previous infection with other viruses such 
as dengue, that have a part to play in the likelihood of ZIKV 
infection? How long does the virus persist in the host? If a 
woman becomes pregnant some years following initial infec-
tion, is the foetus still at risk of developing microcephaly? 
Questions of epidemiology are difficult to answer, and some 
would require a global retrospective study to provide any 
solutions. Studies comparing various strains of the virus and 
their effects on various cells derived from different human 
populations may aid in answering some of these questions, 
determining specific molecular and cellular vulnerability.
Secondly, is it possible to pinpoint infection to a spe-
cific viral protein or Zika-derived small RNA? How would 
these individual components elicit specified effects on spe-
cific cellular properties? Studies investigating these specific 
interactions would aid in understanding the pathogenesis of 
ZIKV infection and in developing therapeutics to target this 
interaction.
Thirdly, why are neural progenitor cells so susceptible to 
infection with the virus? What factors and pathways mediate 
this entry and infection? Are NPCs particularly susceptible 
due to their direct interaction with the cerebrospinal fluid, or 
specifically due to their receptor profile and high expression 
of ZIKV entry receptors? Finding the specific interaction 
that allows the virus to infect cells, particularly NPCs, may 
be essential in developing therapeutics for ZIKV infection.
Finally, what role does the host immune system play in 
the infection with ZIKV? Does the virus manipulate immune 
cells in order to facilitate its destructive path through the 
body? What role do glia and microglia play in brain develop-
ment deficits exhibited during ZIKV infection?
It is clear that there is a relationship between Zika virus 
infection and microcephaly, but more research needs to be 
done to establish the facts and therefore provide methods of 
controlling or limiting disease caused by ZIKV.
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